Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy with 1 year of bevacizumab.
Critère d'inclusion
- Early primary invasive adenocarcinoma of the breast (triple negative and/or basal-like phenotype)